SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: billy d who wrote (383)8/21/1997 11:52:00 PM
From: James Silverman   of 10280
 
Billy, why don't you look up how much SEPR paid for CHRX?
Also the GLX deal is what has propelled CHRX and I have reason to believe that the deal would not have been made had Sepracor (levalbuterol competes with GLX Albuterol) kept their stake and remained on the board. So by stepping aside, they may have helped seal the deal. Just speculation of course.
You are correct that BSEP and HMSR have not worked out as they would have liked, to say the least.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext